By Erin Marie Daly ( March 27, 2009, 12:00 AM EDT) -- Bristol-Myers Squibb Co. has agreed to fork over $2.1 million to settle allegations by the U.S. Federal Trade Commission that the drugmaker issued misleading statements about a proposed Plavix patent deal with Apotex Corp. in 2006, violating court orders stemming from two earlier antitrust cases....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.